Key facts
- It has raised $94.5M; the latest was Early Stage VC ($50.0M) in Oct 2024.
- Notable investors include MedTech Innovator, European Union, INNVIERTE SICC, VSquared Ventures, CDTI Innvierte — 23 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for INBRAIN Neuroelectronics
- ·The full record, as it builds
Funding rounds
No funding rounds for INBRAIN Neuroelectronics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About INBRAIN Neuroelectronics
Operator of a medical device company intended to provide real-time precision neurology and resolution graphene intelligent neural systems. The company uses graphene to develop a full implantable platform with neural interfaces that can decode and modulate brain activity at high resolution, detecting therapy-specific biomarkers and triggering focal adaptive responses, enabling patients to obtain optimal therapeutic outcomes and using technology in neuro and bioelectronic applications.
- Sector
- Healthcare
- HQ
- Barcelona, Spain
- Founded
- 2020
- Employees
- 85
- Ownership
- Privately Held (backing)
INBRAIN Neuroelectronics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in INBRAIN Neuroelectronics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on INBRAIN Neuroelectronics in its N-PORT filings yet. We sweep new filings monthly.